Combination treatment significantly enhances the efficacy of antitumor therapy by preferentially targeting angiogenesis
- 1 June 2005
- journal article
- Published by Elsevier in Laboratory Investigation
- Vol. 85 (6) , 756-767
- https://doi.org/10.1038/labinvest.3700272
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Angiopoietin-3 Inhibits Pulmonary Metastasis by Inhibiting Tumor AngiogenesisCancer Research, 2004
- Acquired resistance to EGFR inhibitors: mechanisms and prevention strategiesInternational Journal of Radiation Oncology*Biology*Physics, 2004
- Targeting tumor cells by enhancing radiation sensitivityGenes, Chromosomes and Cancer, 2003
- Src and phosphatidylinositol 3–kinase mediate soluble E-selectin–induced angiogenesisBlood, 2003
- Endothelial Apoptosis as the Primary Lesion Initiating Intestinal Radiation Damage in MiceScience, 2001
- Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death MachineryCell, 1997
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisPublished by Elsevier ,1996
- The combination of antiagniogenic agents to inhibit primary tumor growth and metastasisJournal of Pediatric Surgery, 1993
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971